Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT03312530
Brief Title: A Study of Cobimetinib Administered as Single Agent and in Combination With Venetoclax, With or Without Atezolizumab, in Participants With Relapsed and Refractory Multiple Myeloma

First Submitted : October 12, 2017
First Submitted that Met QC Criteria : October 12, 2017
First Posted : October 17, 2017

Last Update Submitted that Met QC Criteria : August 5, 2021
Last Update Posted : August 6, 2021